Food, Chemical & Pharmaceutical Law
Conference | 27.02.2019 | Basel | Language: English

Big Data in the Pharmaceutical Sector between Protection and Transparency: Opportunities and Legal Challenges

Data in the healthcare and pharmaceutical sector play an important role in various aspects. Data has already transformed many facets of the sector. Huge datasets are driving new drug discoveries and are making clinical trials more efficient. Wearable devises such as sleep trackers are creating more informed patients and the employment of more sophisticated data models has enabled healthcare professionals better to predict and prevent illness. From personalised medicine to AI assisted diagnostics and genetic engineering and sequencing, the possibilities, it seems, are endless.

However, despite its potential to improve patient care and the share price of pharmaceutical companies, legal and regulatory challenges remain. One need to look no further than the recent introduction of the General Data Protection Regulation (GDPR) to realise that significant regulatory challenges exists. With patients and regulatory becoming increasingly cognizant of data protection issues, regulatory restrictions are only going to increase.

Contact form
Die mit * markierten Felder sind Pflichtfelder.



This one-day conference is specifically designed to help you navigate these challenges and recognise opportunities. Aimed at practitioners, regulators and academics alike, this event will help to avoid legal pitfalls and embrace opportunities as the healthcare sector enters into the era of big data.

During the conference the following topics will be discussed:

  • Big data in the pharmaceutical sector – Current developments and legal challenges
  • Data protection issues resulting from personalized medicine and pay for performance (P4P)
  • Regulator’s standpoint
  • Using data to reduce the number of clinical trials: Regulatory issues
  • The case for ‘open source’ pharma
  • How eliminating data silos will democratize pharma R&D
  • Blockchain and datasharing in the pharma sector

Who should participate?

  • Inhouse Legal Counsel
  • Compliance and Data Protection Officer
  • Regulatory Affairs Officer
  • Life Science Attorneys
  • Regulators
  • Academics
  • Researchers

If you are interested, please use our Newletter to stay informed about our upcoming conferences, workshops, trainings and current published journals in our core areas of EU competition, data protection, substances and environmental law, as well as exciting new projects in emerging technologies and digitalisation.

Don’t miss any news and sign up for our free news alert.  Sign up now